NVS

Novartis AG Sponsored ADR · NYSE

Sector Health Technology
Industry Pharmaceuticals: Major
Website novartis.com
Employees(FY) 101703
ISIN US66987V1098

Performance

-1.74%

-12.02%

-11.08%

+0.51%

+5.37%

YTD

+11.7%

Profile

Novartis AG researches, develops, manufactures, and markets healthcare products in Switzerland and internationally. The company offers prescription medicines for patients and physicians. It focuses on therapeutic areas, such as cardiovascular, renal and metabolic, immunology, neuroscience, and oncology, as well as ophthalmology and hematology. Novartis AG has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran, a therapy to reduce LDL cholesterol. Novartis AG was incorporated in 1996 and is headquartered in Basel, Switzerland.

Advanced Technical Analysis

Technical Analysis of NVS 2024-11-20

The stock indicators reflect a bearish sentiment overall, with a Moving Average Score of 10 indicating strong downward momentum, an Oscillators Score of 46 suggesting a neutral stance, and a Technical Score of 28 reinforcing the bearish outlook. This combination signals caution for potential investors, as the prevailing trend appears to be negat...

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of NVS

Stock Rank

Recent News & Updates

2024-11-20 12:00
Novartis upgrades mid-term guidance and highlights deep pipeline in core therapeutic areas to drive long-term growth(Yahoo Finance)
2024-11-19 17:35
Astellas application rejected by FDA; Cytokinetics strikes licensing deal with Bayer(Yahoo Finance)
2024-11-19 08:00
Novartis ranks first in 2024 Access to Medicine Index(GlobeNewswire)
2024-11-19 07:45
Novartis strengthens radiopharma leadership with Ratio Therapeutics deal(Pharmaceutical Technology)
2024-11-18 19:00
Ratio Enters License and Collaboration Agreement with Novartis for SSTR2-targeting Radiotherapeutic Candidate(Prnewswire)
2024-11-18 09:45
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick(Zacks)
2024-11-18 09:14
Novartis Pharma, Ratio Therapeutics Collaborate to Develop Cancer Treatment Candidate(MT Newswires)
2024-11-18 08:00
Ratio Enters License and Collaboration Agreement with Novartis for SSTR2-targeting Radiotherapeutic Candidate(PR Newswire)
2024-11-17 23:44
Analyst Report: Novartis AG(Yahoo Finance)
2024-11-15 20:40
Here's Why Novartis (NVS) is a Strong Value Stock(Yahoo Finance)
2024-11-15 12:40
FDA reviews Sanofi and Regeneron’s Dupixent label expansion for urticaria(Pharmaceutical Technology)
2024-11-15 11:51
Novartis Says Talks for Prostate Cancer Treatment Close Without Deal(MT Newswires)
2024-11-15 09:47
Kodiak Q3 Loss Narrower Than Expected, Pipeline Development in Focus(Zacks)
2024-11-15 08:46
Ouch: Why a Healthcare Selloff Really Hurts in Europe(The Wall Street Journal)
2024-11-14 09:35
Down -10.9% in 4 Weeks, Here's Why You Should You Buy the Dip in Novartis (NVS)(Zacks)
2024-11-14 02:46
Zacks.com featured highlights include Janus Henderson, Coastal Financial, Novartis, Apogee and InterDigital(Zacks)
2024-11-13 09:55
Novartis (NVS) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now(Zacks)
2024-11-13 09:35
Down -9.72% in 4 Weeks, Here's Why You Should You Buy the Dip in Novartis (NVS)(Zacks)
2024-11-13 08:44
5 Low-Leverage Stocks to Buy Amid the Focus on Inflation Data(Zacks)
2024-11-13 08:37
Q3 2024 Voyager Therapeutics Inc Earnings Call(Thomson Reuters StreetEvents)
2024-11-13 06:56
Schrodinger announces expanded license agreement with Novartis(TipRanks)
2024-11-13 06:15
Amgen shares sink on obesity drug concerns; AstraZeneca to spend $3.5B on manufacturing(BioPharma Dive)
2024-11-13 03:28
Q3 2024 Legend Biotech Corp Earnings Call(Thomson Reuters StreetEvents)
2024-11-13 02:06
Schrodinger Inc (SDGR) Q3 2024 Earnings Call Highlights: Navigating Revenue Challenges and ...(GuruFocus.com)
2024-11-13 00:54
Q3 2024 Schrodinger Inc Earnings Call(Thomson Reuters StreetEvents)
2024-11-12 16:16
Top Stock Reports for Netflix, Salesforce & Cisco(Zacks)
2024-11-12 11:06
Schrödinger Scores Big Despite Q3 Miss As Novartis Collaboration Promises Billions In Milestones: Details(Benzinga)
2024-11-12 09:41
Schrodinger Signs Research Partnership With Novartis for New Drug Discovery, Development(MT Newswires)
2024-11-11 11:40
NVS or LLY: Which Is the Better Value Stock Right Now?(Zacks)
2024-11-08 12:02
Nektar Q3 Loss Narrower Than Expected, Pipeline Development in Focus(Zacks)

Page 1 of 10

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.